BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Vaxcyte Inc. – Underwriting Agreements

NASDAQ: PCVX    
Share price (9/11/26): $59.47    
Market cap (9/11/26): $8.849 billion
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 36 pages Sales Agreement
12/34/56
EX-1.1
from 8-K 42 pages Vaxcyte, Inc. (A Delaware Corporation) 11,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Vaxcyte, Inc. (A Delaware Corporation) 10,194,175 Shares of Common Stock and Pre-Funded Warrants to Purchase 2,427,184 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages Vaxcyte, Inc. (A Delaware Corporation) 10,937,500 Shares of Common Stock and Pre-Funded Warrants to Purchase 781,250 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Vaxcyte, Inc. (A Delaware Corporation) 11,200,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 1,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 4 pages Amendment No. 1 to the Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 42 pages Vaxcyte, Inc. (A Delaware Corporation) 15,000,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 3,750,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages Vaxcyte, Inc. (A Delaware Corporation) 2,500,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 2,500,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3ASR 41 pages Open Market Sale Agreementsm
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 37 pages Vaxcyte, Inc. (A Delaware Corporation) [ 🌑 ] Shares of Common Stock Underwriting Agreement
12/34/56